43 employees
Curie Therapeutics is a fully integrated next-generation radiopharmaceutical firm that combines ligand research and radiochemistry experts.
2020
$75M
from 2 investors over 2 rounds
Curie Therapeutics raised $75M on December 1, 2021
Investors: RA Capital Management, L.P. and Atlas Venture